Novo Nordisk
NVO
NVO
461 hedge funds and large institutions have $8.41B invested in Novo Nordisk in 2014 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 147 increasing their positions, 184 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
20% less repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 184
53% less call options, than puts
Call options by funds: $8.45M | Put options by funds: $18M
65.67% less ownership
Funds ownership: 82.19% → 16.52% (-66%)
Holders
461
Holding in Top 10
28
Calls
$8.45M
Puts
$18M
Top Buyers
| 1 | +$178M | |
| 2 | +$109M | |
| 3 | +$46.2M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$29.6M |
| 5 |
AG
Aperio Group
Sausalito,
California
|
+$25.4M |
Top Sellers
| 1 | -$116M | |
| 2 | -$70.8M | |
| 3 | -$39.8M | |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$37.3M |
| 5 |
PI
Placemark Investments
Chicago,
Illinois
|
-$27.1M |